FDA issued a 510(k) submission guidance as a special control for Immunomagnetic Circulating Cancer Cell Selection and enumeration systems. This guidance references FDA’s software submission guidances and indicates that software in such devices should be considered of Moderate Level of Concern in preparing software submission information. A copy of the guidance is at the link provided.
SoftwareCPR keywords: OIVD